Pure Global

Ultrasound Versus Palpation for Spinal Anesthesia Success - Trial NCT03679663

Access comprehensive clinical trial information for NCT03679663 through Pure Global AI's free database. This phase not specified trial is sponsored by Tel-Aviv Sourasky Medical Center and is currently Completed. The study focuses on Ultrasound. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT03679663
Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT03679663
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Ultrasound Versus Palpation for Spinal Anesthesia Success
Prospective Randomized Controlled Trial to Compare a Handheld Ultrasound Identification of the Neuraxial Block Insertion Site Versus Palpation Only in an Obese Population of Women Undergoing Cesarean Delivery

Study Focus

Ultrasound

Ultrasound

Interventional

device

Sponsor & Location

Tel-Aviv Sourasky Medical Center

Tel Aviv, Israel

Timeline & Enrollment

N/A

Dec 20, 2018

Aug 04, 2020

40 participants

Primary Outcome

Needle movement

Summary

Aim is to investigate the difference in number of attempts to place neuraxial block comparing
 handheld ultrasound versus use of palpation alone for women with impalpable bony landmarks
 undergoing spinal anesthesia for elective cesarean delivery.

ICD-10 Classifications

Abnormal ultrasonic finding on antenatal screening of mother
Antenatal screening for malformations using ultrasound and other physical methods
Antenatal screening for fetal growth retardation using ultrasound and other physical methods
Other diagnostic agents
Examination of ears and hearing

Data Source

ClinicalTrials.gov

NCT03679663

Device Trial